Clinical Trial Update: SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating Symbicort (budesonide/formoterol) for persistent asthma in adolescents and adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED